AbCellera’s T-cell engager (TCE) platform has reeled in a second client this summer, with Vertex Pharmaceuticals ...

There are other reasons to pay attention to Viking Therapeutics.

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other ...

AbCellera (Nasdaq: ABCL) today announced a collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to research, develop, manufacture, and commercialize multispecific T-cell engagers ...

A seasoned leader in refining, renewable fuels, and clean-energy infrastructure joins Alléo as it scales its proprietary ...

Vertex Pharmaceuticals Inc. VRTX shares are up during Tuesday’s premarket session following positive interim results from one of its Phase 3 trials. The stock’s rise comes as the company is reportedly ...

Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella’s inaugural ...

"We are reiterating our 2026 total revenue guidance of $12.95 billion to $13.1 billion, representing growth of 8% to 9%" (CFO Wagner). "We continue to have high confidence in our outlook for revenue ...

BioProcess International learned about how advanced therapy developers and manufacturers are adapting to changing ...

DOHA: Qatar University (QU) is accelerating the integration of artificial intelligence across its academic and administrative operations as part of a broader digital transformation strategy aimed at ...

Secure artificial intelligence infrastructure startup Dymium Inc. today introduced GhostAI, a gateway designed to apply ...

Unitek Learning today announced the launch of a new paramedic program in Tempe, Arizona, marking a significant expansion of ...